GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV SeasonsBusiness Wire • 10/08/24
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reportsReuters • 10/04/24
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIXBusiness Wire • 09/18/24
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles RiskPRNewsWire • 09/16/24
Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical OfficerNewsfile Corp • 09/16/24
GSK drug promotes ‘significant and clinically meaningful reduction' in asthma symptomsProactive Investors • 09/09/24